Award
NIH Reporter #1R21HL188689-01
Derivation and validation of a clinical prediction rule to identify febrile children and adolescents with sickle cell disease at low risk for bacteremia
Recipient
Yale University
Award Amount
$313,649.00
Ceiling
$313,649.00
Awarded
August 11, 2026
Identifier
1R21HL188689-01
This NIH/NHLBI funded project at Yale University seeks to create and validate a clinical prediction rule to identify febrile children with sickle cell disease at low risk for bacteremia, aiming to reduce unnecessary antibiotic use and hospitalizations.
Description
The project aims to develop a clinical prediction rule to identify children with sickle cell disease and fever at low risk for blood infection who can be safely discharged without antibiotics. It involves deriving and validating a clinical prediction rule using demographic, clinical, and laboratory data from the PECARN Registry and external validation in a multicenter prospective study.